References
Krivak TC, Zorn KK (2007) Venous thromboembolism in obstetrics and gynecology. Obstet Gynecol 109:761–777
Greer IA (2004) Prevention of venous thromboembolism in pregnancy. Eur J Med Res 9:135–145
Duhl AJ, Paidas MJ, Ural SH, Branch W, Casele H, Cox-Gill J et al (2007) Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol 197:457.e1–21
Savage DG, Szydlo RM, Goldmann JM (1997) Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol 96:111–116
Wehmeier A, Daum I, Jamin H, Schneider W (1991) Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hematol 63:101–106
Östergren J, Fagrell B, Björkholm M (1992) Hyperleukocytic effects on skin capillary circulation in patients with leukaemia. J Intern Med 231:19–23
Kessler CM (2004) Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders. Semin Hematol 41(suppl 3):10–14
Acknowledgement
The authors want to express their sincere gratitude to all responding experts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Björkholm, M., Ohm, L. & Stenke, L. Chronic myeloid leukemia presenting late in pregnancy. Report of a case and a questionnaire reflecting diversity in management options. Ann Hematol 88, 173–175 (2009). https://doi.org/10.1007/s00277-008-0549-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0549-x